(Q44169297)

30 November 2017

Peripheral injection of risperidone, an atypical antipsychotic, alters the bodyweight gain of rats (English)

1 reference

30 November 2017

1 reference

Miyuki Ota

1

1 reference

30 November 2017

Keiji Mori

2

1 reference

30 November 2017

Akira Nakashima

3

1 reference

30 November 2017

Yoko S Kaneko

4

1 reference

30 November 2017

Kentaro Fujiwara

5

1 reference

30 November 2017

Mitsuyasu Itoh

6

1 reference

30 November 2017

Akio Nagasaka

7

1 reference

30 November 2017

Akira Ota

8

1 reference

30 November 2017

1 November 2002

1 reference

Clinical and Experimental Pharmacology and Physiology

30 November 2017

1 reference

30 November 2017

29

1 reference

30 November 2017

11

1 reference

30 November 2017

980-989

1 reference

Too many chronic mentally disabled patients are too fat.

30 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Prevalence of obesity in patients receiving depot antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Clozapine-induced weight gain: prevalence and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Different side effect profiles of risperidone and clozapine in 20 outpatients with schizophrenia or schizoaffective disorder: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Atypical antipsychotics and weight gain--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Weight gain in adolescents treated with risperidone and conventional antipsychotics over six months

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Body weight gain induced by antipsychotic drugs: mechanisms and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Serum leptin levels increase rapidly after initiation of clozapine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Weight-reducing effects of the plasma protein encoded by the obese gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Effects of the obese gene product on body weight regulation in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Antipsychotic drug-induced obesity in rats: correlation between leptin, insulin and body weight during sulpiride treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Thermogenic mechanisms in brown fat

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Mechanism and evolution of the uncoupling protein of brown adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Effects of long-term administration of clozapine on body weight and food intake in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Hypothalamic serotonin in control of eating behavior, meal size, and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Leptin-independent hyperphagia and type 2 diabetes in mice with a mutated serotonin 5-HT2C receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Feeding behavior in dopamine-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Dopamine is required for hyperphagia in Lep(ob/ob) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Effects of intracerebroventricularly infused histamine and selective H1, H2 and H3 agonists on food and water intake and urine flow in Wistar rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Targeted disruption of histamine H1-receptor attenuates regulatory effects of leptin on feeding, adiposity, and UCP family in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Behavioural and physiological effects induced by an infusion of antisense to alpha(2D)-adrenoceptors in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Expression of human alpha 2-adrenergic receptors in adipose tissue of beta 3-adrenergic receptor-deficient mice promotes diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Identification of targets of leptin action in rat hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Regulation of hypothalamic proopiomelanocortin mRNA by leptin in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

The role of neuropeptide Y in the antiobesity action of the obese gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Hypothalamic hypocretin/orexin and neuropeptide Y: divergent interaction with energy depletion and leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

The uncoupling protein homologues: UCP1, UCP2, UCP3, StUCP and AtUCP

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Brown adipose tissue thermogenesis and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Receptor-mediated regional sympathetic nerve activation by leptin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Pharmacologic manipulation of ob expression in a dietary model of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Activation of beta(3) adrenergic receptors suppresses leptin expression and mediates a leptin-independent inhibition of food intake in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Effects of beta-adrenoceptor subtype stimulation on obese gene messenger ribonucleic acid and on leptin secretion in mouse brown adipocytes differentiated in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Conditions of forming protein complexes with GroEL can influence the mechanism of chaperonin-assisted refolding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Beta 3- and alpha1-adrenergic Erk1/2 activation is Src- but not Gi-mediated in Brown adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Prolactin stimulates leptin secretion by rat white adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

A prolactin-releasing peptide in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Alternative role for prolactin-releasing peptide in the regulation of food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

Role of leptin in fat regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1681.2002.T01-1-03755.X

10.1046/J.1440-1681.2002.T01-1-03755.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference